Medications & Supplements/Prescription Drugs

Ibuprofen Tablets Recalled for Failed Impurities and Degradation Testing

Agency Publication Date: August 26, 2024

Summary

Preferred Pharmaceuticals, Inc. is recalling 266 bottles of Ibuprofen Tablets, USP 400mg, which is a generic version of Motrin. The recall was issued after 18-month stability testing revealed that the tablets failed to meet required specifications for impurities and degradation. These tablets were manufactured by Dr. Reddy's Laboratories and are packaged in bottles containing 30 tablets each.

Risk

The tablets may contain impurities or degradation products that exceed safety limits, which could potentially compromise the safety or effectiveness of the medication.

What You Should Do

This recall affects Ibuprofen Tablets, USP 400mg (Generic for Motrin) sold in 30-count bottles with NDC 68788-9110-03.
Check your medication bottle for lot numbers B0223H (expiration date 5/31/2026) or C3023H (expiration date 9/30/2026).
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals, Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Ibuprofen Tablets, USP 400mg (30 tablets)

Variants: 400mg, Tablet

Lot Numbers:

B0223H (Exp 5/31/2026)

C3023H (Exp 9/30/2026)

NDC:

68788-9110-03

Manufactured by Dr. Reddy's Laboratories, Shreveport, Louisiana.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 95132

Status: Active

Manufacturer: Preferred Pharmaceuticals, Inc.

Manufactured In: United States

Units Affected: 266 bottles

Distributed To: California, Nevada

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Ibuprofen Tablets, USP 400mg (Generic for Motrin) sold in 30-count bottles with NDC 68788-9110-03.

Check your medication bottle for lot numbers B0223H (expiration date 5/31/2026) or C3023H (expiration date 9/30/2026).

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals, Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).